Site Members can sign up for company wide alerts
Lawsuit Overview
April 17, 2025 - An investor in shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Zenas BioPharma, Inc. in connection with certain allegedly false and misleading statements made in connection with Zenas BioPharma’s September 2024 initial public offering (the ...
You must register (for free) or login to view the entire case.